Stock Events

Stock Events

Vyne Therapeutics (VYNE) Q3 2024 Earnings

14AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-1.97

-1.36

-0.76

-0.15

Details

Expected EPS

-0.19

Actual EPS

-0.22

Surprise EPS

-0.03

Surprise Percent

+15.79%

Description

Vyne Therapeutics (VYNE) has reported earnings of -0.22 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.